AstraZeneca's £450m UK Vaccine Plant Faces Funding Uncertainty

Chancellor Rachel Reeves' review of state aid threatens to reduce support for the Merseyside project, raising relocation concerns.

• The UK government initially committed £65m to AstraZeneca's vaccine-manufacturing facility in Speke.
• Chancellor Rachel Reeves is considering cutting this aid by more than £20m as part of a broader fiscal review.
• AstraZeneca's project, crucial for domestic vaccine production, may move abroad if funding is insufficient.
• The potential funding cut contradicts the government's pro-growth rhetoric and commitment to life sciences.
• Ongoing discussions aim to resolve the funding gap and secure the project's future in the UK.

3 Articles

The Guardian The Telegraph The Guardian